“FDA is late to the table on cannabis”: CSPI urges agency to act on regulating CBD

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

27 Mar 2020 --- In light of the COVID-19 pandemic, the US Food and Drug Administration (FDA) is granting temporary flexibility to restaurants and food manufacturers in the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

25 Mar 2020 --- Cannabinoids, including cannabidiol (CBD), have been under the microscope as easing regulation has enabled research to flourish. According to researchers from the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

24 Mar 2020 --- In the age of “fake news,” it is important that consumers are not misled by advertising, with global watchdogs keen to keep companies in line. With this... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

24 Mar 2020 --- In the midst of a hazy regulatory environment surrounding cannabidiol (CBD) and its uses, many industry players are recognizing the ingredient’s potential and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

19 Mar 2020 --- The US Food and Drug Administration (FDA) has temporarily postponed all domestic routine surveillance facility inspections to protect the health of its staff during... Read More

trans